Towards Healthcare
Structural Biology and Molecular Modeling Market to Rise at 15.51% CAGR till 2...

Structural Biology and Molecular Modeling Market Rises with AI Driven Protein Insights

According to market projections, the structural biology and molecular modeling sector is expected to grow from USD 9.55 billion in 2025 to USD 40.4 billion by 2035, reflecting a CAGR of 15.51%. The growing drug discovery research and increasing R&D investments drive the global market. The availability of state-of-the-art R&D facilities and the presence of key players contribute to North America’s dominance.

Content

  • Last Updated: 19 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The structural biology and molecular modeling market stands at USD 11.03 billion in 2026 and is expected to reach USD 40.4 billion by 2035, growing at a CAGR of 15.51% from 2026 to 2035.

North America is leading the structural biology and molecular modeling market share by 41% due to the availability of state-of-the-art research and development facilities and the presence of key players.

The structural biology and molecular modeling market includes 6 segments by application, by tool, technique, by component, by end-user, by therapeutic area, and by region.

Some key players include Schrodinger, Inc., Dassault Systèmes, and DeepMind.

Key trends include the increasing drug discovery research, increasing investments, and advancements in molecular modeling.

Some common types of molecular models include the ball-and-stick model, the space-filling model, and the skeletal structure.

Structural biology is mainly used to understand the molecular components and mechanisms underlying human diseases.
Any Questions